Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 16, 2025
Ethanol intoxication in paediatric patients receiving intravenous etoposide as conditioning regimen for allogenic hematopoietic stem cell transplantPauline Claraz, Marie de Tersant, Valentine Feyants, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Isavuconazole Treatment for Invasive Fungal Infections in Pediatric PatientsPhilippe Zimmermann, Benoit Brethon, Julie Roupret-Serzec, et al.
International Journal of Pharmaceutics|July 27, 2025
Opensource semi-solid 3D printer designed for oral drug production in hospital pharmaciesFrançois Rioblanc, Baptiste Heumel, Daniel Alloh Nammou, et al.
Glia|December 25, 2024
Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF-1RDavid Guenoun, Nathan Blaise, Alexandre Sellam, et al.
Frontiers in Oncology|March 15, 2021
Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged LeukemiaBenoît Brethon, Elodie Lainey, Aurélie Caye-Eude, et al.
British Journal of Haematology|October 25, 2024
Monocentric experience of venetoclax-based regimen in paediatric refractory and relapsed AML/MDSSophie Cousson, Charlotte Calvo, Lauriane Goldwirt, et al.
Leukemia|May 18, 2021
Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemiaMarie-Emilie Dourthe, Florence Rabian, Karima Yakouben, et al.
Leukemia|February 24, 2026
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemiaNicolas Lecornec, Florence Rabian, Marie-Emilie Dourthe, et al.
Pageof 1